阿尔茨海默病和癌症:共同的目标
Xueqing Yang1, Jinlian Dai1, Chenglong Wu1
1School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, China.
癌症和阿尔茨海默病 (AD) 可能具有共同的分子机制,具有潜在的治疗点,如GSK3和P53,为这两种疾病提供新的药物开发途径.
科学领域:
- 在瘤学瘤学.
- 神经科学是一个神经科学.
- 分子生物学分子生物学
背景情况:
- 越来越多的证据表明,癌症和阿尔茨海默病 (AD) 之间存在反向关联.
- 共享的信号通路调节细胞生存和死亡,这意味着它们的调节失调在癌症和AD病变发生过程中.
- 越来越多地认识到癌症和AD之间的共同分子基础.
研究的目的:
- 审查特定分子点在癌症和AD病变发生过程中的作用.
- 讨论药物开发的现状,以这些共同途径为目标.
主要方法:
- 对调查癌症和AD分子机制的研究进行文献综述.
- 对糖原合成酶激酶3 (GSK3),死亡相关蛋白激酶1 (DAPK1),蛋白酸酶2A (PP2A),瘤蛋白P53 (P53) 和大麻素受体2 (CB2R) 的作用进行分析.
主要成果:
- GSK3,DAPK1,PP2A,P53和CB2R都与癌症和AD的共同分子途径有关.
- 这些目标代表了两种疾病治疗干预的潜在点.
结论:
- 已确定的分子标 (GSK3,DAPK1,PP2A,P53,CB2R) 为开发具有双重疗效的抗癌药物提供了有前途的途径.
- 对这些共同机制的进一步研究可能会导致针对这些复杂疾病的新型治疗策略.
更多相关视频
09:33Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
04:41Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
相关概念视频
Psychoneuroimmunology: Diabetes and Cancer
Targeted Cancer Therapies
There are several types of targeted therapies against...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Cancer
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
